Form 8-K - Current report:
SEC Accession No. 0000950170-25-088494
Filing Date
2025-06-20
Accepted
2025-06-20 16:05:29
Documents
22
Period of Report
2025-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20250618.htm   iXBRL 8-K 65348
2 EX-4.1 apvo-ex4_1.htm EX-4.1 200067
3 EX-4.2 apvo-ex4_2.htm EX-4.2 172445
4 EX-10.1 apvo-ex10_1.htm EX-10.1 222366
5 EX-10.2 apvo-ex10_2.htm EX-10.2 333625
6 EX-99.1 apvo-ex99_1.htm EX-99.1 18126
7 EX-99.2 apvo-ex99_2.htm EX-99.2 18496
8 EX-99.3 apvo-ex99_3.htm EX-99.3 33109
9 EX-99.4 apvo-ex99_4.htm EX-99.4 25226
10 GRAPHIC img237228349_0.jpg GRAPHIC 14823
11 GRAPHIC img238151870_0.jpg GRAPHIC 14823
12 GRAPHIC img239075391_0.jpg GRAPHIC 14823
13 GRAPHIC img239998912_0.jpg GRAPHIC 8764
  Complete submission text file 0000950170-25-088494.txt   1455078

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20250618.xsd EX-101.SCH 26037
24 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20250618_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 251061322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)